Akèy › Kansè tèt ak kou › Distrik Columbia › Washington
Etid klinik pou Kansè tèt ak kou nan Washington, DC
10 etid pou Kansè tèt ak kou ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Biospecimen Procurement for Head and Neck Disorders
Ap rekriteEtid obsèvasyon
- MedStar Georgetown University Hospital, Washington D.C.
- Johns Hopkins Hospital Sibley Memorial Hospital, Washington D.C.
- George Washington University Hospital, Washington D.C.
- ak 3 plis
[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Ap rekriteFaz 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
Ap rekriteFaz 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- National Institutes of Health, Bethesda · 7 mi lwen
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
Ap rekriteVolontè an sante akeyi
- Sibley Memorial Hospital, Washington D.C.
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Ap rekriteFaz 3
- GSK Investigational Site, Washington D.C.
X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
Ap rekriteFaz 1
- Sibley Hospital - Johns Hopkins University, Washington D.C.
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Ap rekriteFaz 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi lwen
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi lwen
Etid Kansè tèt ak kou nan lòt vil
- Houston, TX30 etid
- Boston, MA22 etid
- Nashville, TN21 etid
- New York City, NY21 etid
- St. Louis, MO15 etid
- Dallas, TX12 etid
- Pittsburgh, PA11 etid
- San Antonio, TX10 etid
- Los Angeles, CA10 etid
- Baltimore, MD10 etid
- Durham, NC10 etid
- Chicago, IL10 etid
Lòt etid nan Washington
- Kansè (tout kalite)58 etid
- Kansè Poumon ki pa ti selil55 etid
- Kansè nan tete46 etid
- Kansè Metastatik43 etid
- Kansè poumon41 etid
- Kansè pwostat38 etid
- Obèsite33 etid
- Kansè kolorektal29 etid
- Maladi kadyovaskilè28 etid
- Kansè vejik26 etid
- Leksemi mieloïd egi24 etid
- Kansè ovè23 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.